Evidence map›Paper›PMID 35576232›Full record

ArticlePLoS pathogens2022

Ehrlichia SLiM ligand mimetic activates Hedgehog signaling to engage a BCL-2 anti-apoptotic cellular program.

Caitlan D Byerly, Shubhajit Mitra, LaNisha L Patterson, Nicholas A Pittner, Thangam S Velayutham, Slobodan Paessler, Veljko Veljkovic, Jere W McBride

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Cell signaling inFrontiers in cellular and infection microbiology · 2025
    Review
  6. mBio · 2024
    Article
  7. Frontiers in cell and developmental biology · 2024
    Article
  8. Infection and immunity · 2023
    Article
  9. Infection and immunity · 2023
    Article
  10. bioRxiv : the preprint server for biology · 2023
    Article
  11. Type 1 secretion system and effectors in Rickettsiales.Frontiers in cellular and infection microbiology · 2023
    Review
  12. Frontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Caitlan D ByerlyDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.ORCID 0000-0002-3448-0669
Shubhajit MitraDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
LaNisha L PattersonDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Nicholas A PittnerDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Thangam S VelayuthamDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Slobodan PaesslerDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Veljko VeljkovicBiomed Protection, LLC, Galveston, Texas, United States of America.
Jere W McBrideDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.ORCID 0000-0003-3335-1539
The University of Texas Medical Branch at Galveston · USBiomed Protection (United States) · US

Funding

EMERGING AND TROPICAL INFECTIOUS DISEASEST32AI007526 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SOONG, LYNN · 1997 to 2025
$3.1M
Sonic Hedgehog Regulation of Apoptosis During Ehrlichia InfectionR21AI137779 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2019 to 2020
$435k
Molecular basis of Wnt activation by Ehrlichia Wnt ligand mimicsR21AI149136 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2020 to 2021
$426k
Characterizing Notch Ligand Mimic Function of the Ehrlichia TRP120 Effector in Suppression of Host Cell ApoptosisF31AI152424 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PATTERSON, LANISHA · 2020 to 2021
$69k
NIAID NIH HHS F31 AI152424NIAID NIH HHS R21 AI137779NIAID NIH HHS R21 AI149136NIAID NIH HHS T32 AI007526
6 · The paper itself

Abstract

Ehrlichia chaffeensis (E. chaffeensis) has evolved eukaryotic ligand mimicry to repurpose multiple cellular signaling pathways for immune evasion. In this investigation, we demonstrate that TRP120 has a novel repetitive short linear motif (SLiM) that activates the evolutionarily conserved Hedgehog (Hh) signaling pathway to inhibit apoptosis. In silico analysis revealed that TRP120 has sequence and functional similarity with Hh ligands and a candidate Hh ligand SLiM was identified. siRNA knockdown of Hh signaling and transcriptional components significantly reduced infection. Co-immunoprecipitation and surface plasmon resonance demonstrated that rTRP120-TR interacted directly with Hh receptor Patched-2 (PTCH2). E. chaffeensis infection resulted in early upregulation of Hh transcription factor GLI-1 and regulation of Hh target genes. Moreover, soluble recombinant TRP120 (rTRP120) activated Hh and induced gene expression consistent with the eukaryotic Hh ligand. The TRP120-Hh-SLiM (NPEVLIKD) induced nuclear translocation of GLI-1 in THP-1 cells and primary human monocytes and induced a rapid and expansive activation of Hh pathway target genes. Furthermore, Hh activation was blocked by an α-TRP120-Hh-SLiM antibody. TRP120-Hh-SLiM significantly increased levels of Hh target, anti-apoptotic protein B-cell lymphoma 2 (BCL-2), and siRNA knockdown of BCL-2 dramatically inhibited infection. Blocking Hh signaling with the inhibitor Vismodegib, induced a pro-apoptotic cellular program defined by decreased mitochondria membrane potential, significant reductions in BCL-2, activation of caspase 3 and 9, and increased apoptotic cells. This study reveals a novel E. chaffeensis SLiM ligand mimetic that activates Hh signaling to maintain E. chaffeensis infection by engaging a BCL-2 anti-apoptotic cellular program.

Indexed as

Ehrlichia chaffeensisEhrlichiosisBacterial ProteinsHedgehog ProteinsHost-Pathogen InteractionsHumansLigandsProto-Oncogene Proteins c-bcl-2RNA, Small InterferingSignal TransductionBacterial ProteinsHedgehog ProteinsLigandsProto-Oncogene Proteins c-bcl-2RNA, Small Interfering

Identifiers

PMID35576232
PMCPMC9135340
OpenAlexW4280561067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.